scholarly journals Vascular Dysfunction in Women With a History of Preeclampsia and Intrauterine Growth Restriction

Circulation ◽  
2010 ◽  
Vol 122 (18) ◽  
pp. 1846-1853 ◽  
Author(s):  
Yoav Yinon ◽  
John C.P. Kingdom ◽  
Ayodele Odutayo ◽  
Rahim Moineddin ◽  
Sascha Drewlo ◽  
...  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Cande V. Ananth ◽  
Howard F. Andrews ◽  
Panos N. Papapanou ◽  
Angela M. Ward ◽  
Emilie Bruzelius ◽  
...  

2019 ◽  
Vol 220 (1) ◽  
pp. S136
Author(s):  
Andrew H. Chon ◽  
Stephen Y. Ma ◽  
Lisa M. Korst ◽  
Hikmat R. Chmait ◽  
Margaret E. Purnell ◽  
...  

2020 ◽  
Vol 13 (2) ◽  
pp. e232653
Author(s):  
Catherine Davis ◽  
Tanya Nippita

Hyperparathyroidism is a rare disease during pregnancy, which has increased risks, including miscarriage and fetal growth restriction. However, the diagnosis of hyperparathyroidism is frequently not recognised or delayed as symptoms are non-specific and calcium is not routinely measured. With a thorough medical history and clinical suspicion, early diagnosis and treatment can reduce the risk of some pregnancy complications. A 35-year-old woman presented at 13/40 with hyperemesis gravidarum. She had elevated serum calcium and a parathyroid lesion on ultrasound. She underwent a parathyroidectomy with rapid normalisation of her calcium. Histopathology confirmed a parafibromin-deficient parathyroid tumour, suggestive of hyperparathyroidism jaw tumour syndrome. At 30/40, she presented with pre-eclampsia (hypertension, hyper-reflexia, proteinuria and intrauterine growth restriction) and had a caesarean section at 30+1/40, delivering a male infant, 897 g (fifth percentile). She had a prior 12-month history of chronic constipation and nephrolithiasis but was not investigated further despite elevated calcium (2.82 mmol/L).


2017 ◽  
Vol 158 (16) ◽  
pp. 612-617
Author(s):  
Péter Kovács ◽  
Attila Rab ◽  
Imre Szentpéteri ◽  
József Gábor Joó ◽  
László Kornya

Abstract: Placental vascular endothelial growth factor A (VEGF-A) gene and endoglin gene are both overexpressed in placental samples obtained from pregnancies with intrauterine growth restriction compared to normal pregnancies. In the background of these changes a mechanism can be supposed, in which the increased endoglin activity in intrauterine growth restriction (IUGR) leads to impaired placental circulation through an antioangiogenetic effect. This results in the development of placental vascular dysfunction and chronic fetal hypoxia. It is chronic hypoxia that turns on VEGF-A as a compensatory mechanism to improve fetal vascular blood supply by promoting placental blood vessel formation. Although the maternal serum placental growth factor (PlGF) level is a potential predictor for both IUGR and praeeclampsia, placental PlGF gene activity may be less of an active in the regulation of placental circulation in IUGR pregnancies during the later stages of gestation. Orv. Hetil., 2017, 158(16), 612–617.


Sign in / Sign up

Export Citation Format

Share Document